Want to see ONCO full AI Analyst Report?
Onconetix (ONCO) Income Statement
Onconetix Income Statement
Last quarter (Q2 2026), Onconetix's total revenue was $17.12K, a decrease of 83.92% from the same quarter last year. In Q2, Onconetix's net income was $-2.87M. See Onconetix’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 815.37K | $ 2.52M | $ 58.47K | $ 0.00 | $ 0.00 | |
| $ 632.91K | $ 1.06M | $ -1.13M | $ -6.75K | $ -4.89K | |
| $ 6.98M | $ 57.54M | $ 34.91M | $ 13.48M | $ 3.42M | |
| Depreciation and Amortization | $ 15.17K | $ 731.35K | $ 43.94K | $ 6.75K | $ 4.89K |
| $ -13.27M | $ -57.60M | $ -36.71M | $ -13.41M | $ -3.41M | |
| $ -6.34M | $ -56.49M | $ -36.03M | $ -13.48M | $ -3.42M | |
| $ -7.69M | $ -3.25M | $ -1.39M | $ 61.41K | $ 0.00 | |
| $ -14.03M | $ -59.74M | $ -37.42M | $ -13.42M | $ -3.42M | |
| $ -14.03M | $ -58.69M | $ -37.41M | $ -13.42M | $ -3.42M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.73 | $ -520.93 | $ -25.03 | $ -0.31 | $ -0.09 |
| Diluted EPS | $ -4.73 | $ -520.93 | $ -25.03 | $ -0.31 | $ -0.09 |
| Weighted Average Shares Outstanding | 3.28M | 113.05K | 17.61K | 12.63K | 11.37K |
| Weighted Average Shares Outstanding (Diluted) | 3.28M | 113.05K | 17.61K | 12.63K | 11.37K |
Currency in USD
